Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Studies from A.R. Tan et al in the area of breast cancer described
February 5th, 2009
According to a study from the United States, "Triple-negative breast cancer (TNBC) is a clinically relevant term referring to breast carcinomas that do not express the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor type 2 and became operational after human epidermal growth factor receptor type 2 testing was introduced. This is a challenging disease to treat because of the absence of a specific target. but these tumors are sensitive to chemotherapy." "An improved Understanding of the biology of TNBC has led to evaluation Of DNA-damaging chemotherapy drugs. specifically, platinum compounds, and several targeted agents, including...
Source: Women's Health Weekly (2009-02-05)
|
